Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Nir Dotan"'
Autor:
Georgina Arrambide, Carmen Espejo, Jennifer Yarden, Ella Fire, Larissa Spector, Nir Dotan, Avinoam Dukler, Alex Rovira, Xavier Montalban, Mar Tintore
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e59953 (2013)
BackgroundAnti-glycan antibodies can be found in autoimmune diseases. IgM against glycan P63 was identified in clinically isolated syndromes (CIS) and included in gMS-Classifier2, an algorithm designed with the aim of identifying patients at risk of
Externí odkaz:
https://doaj.org/article/642ff7eaad4f4f0ca1d633309f68b14c
Autor:
Florian Rieder, Rocio Lopez, Andre Franke, Alexandra Wolf, Stephan Schleder, Andrea Dirmeier, Anja Schirbel, Philip Rosenstiel, Nir Dotan, Stefan Schreiber, Gerhard Rogler, Frank Klebl
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e18172 (2011)
INTRODUCTION: Anti-glycan antibodies are a promising tool for differential diagnosis and disease stratification of patients with Crohn's disease (CD). We longitudinally assessed level and status changes of anti-glycan antibodies over time in individu
Externí odkaz:
https://doaj.org/article/1d810deb3ea449e8a9f3670e0f4ee6b2
Autor:
Moussa B.H. Youdim, Peter Riederer, Jennifer Yarden, Jose Martin Rabey, Danit Mechlovich, Nir Dotan
Publikováno v:
Rabey, J M, Yarden, J, Dotan, N, Mechlovich, D, Riederer, P & Youdim, M B H 2020, ' Creation of a gene expression classifier for predicting Parkinson’s disease rate of progression ', Journal of Neural Transmission, vol. 127, no. 5, pp. 755-762 . https://doi.org/10.1007/s00702-020-02194-y
Parkinson’s disease (PD) etiology is heterogeneous, genetic, and multi-factorial, resulting in a varied disease from a mild slow progression to a more severe rapid progression. Prognostic information on the nature of the patient’s disease at diag
Autor:
Pier Luigi Meroni, Nir Dotan, Liat Anafi, Ricard Cervera, Yehuda Shoenfeld, Miri Blank, Ilan Krause, Miriam Eisenstein
Publikováno v:
Journal of Autoimmunity. 39:420-427
Objectives We evaluated the presence of anti-glycan antibodies (aGA) in patients with antiphospholipid syndrome (APS), and associations between aGA and clinical features of the disease. Methods Sera from APS patients and healthy controls were analyze
Autor:
Andrea Dirmeier, Frank Klebl, Jennifer Yarden, Florian Rieder, Rocio Lopez, Nir Dotan, Alexandra Wolf, Larissa Spector, Stephan Schleder, Florian Obermeier, Gerhard Rogler, Ulrike Strauch, Ella Fire
Publikováno v:
Inflammatory Bowel Diseases. 16:1367-1375
Background: A high proportion of patients with Crohn's disease (CD) over time develop complications like fistulae and strictures, requiring surgery. We tested a panel of antiglycan antibodies for predicting the occurrence of complications and CD-rela
Autor:
Alexandra Wolf, Rocio Lopez, Stephan Schleder, Frank Klebl, Nir Dotan, Florian Rieder, Ulrike Strauch, Jennifer Yarden, Gerhard Rogler, Ella Fire, Andrea Dirmeier, Florian Obermeier, Larissa Spector
Publikováno v:
Inflammatory Bowel Diseases. 16:263-274
Background: We tested a panel of novel serological anti-glycan antibodies including the previously unpublished anti-laminarin IgA (Anti-L) and anti-chitin IgA (Anti-C) carbohydrate antibodies for the presence in Crohn's disease (CD) patients, diagnos
Autor:
Hayrettin Tumani, Nir Dotan, Dee Husebye, Jennifer Yarden, Johannes Brettschneider, Ella Fire, Troy D. Jaskowski, Sana Abdul, Larissa Spector, John W. Rose, Haniah Seraj, Harry R. Hill
Publikováno v:
Journal of Neuroimmunology. 217:95-101
The serum level of IgM antibodies against Glc(α1,4)Glc(α) (GAGA4) is higher in relapsing remitting multiple sclerosis (RRMS) compared to other neurological disease (OND) patients and healthy controls (HC). Detecting the level of anti-GAGA4 antibody
Autor:
Anne M. Griffiths, Mark S. Silverberg, A. Hillary Steinhart, Cynthia H. Seow, Nir Dotan, Gordon R. Greenberg, Joanne M. Stempak, Hui Lan, Wei Xu
Publikováno v:
The American Journal of Gastroenterology. 104:1426-1434
OBJECTIVES We sought to evaluate whether two novel immunoglobulin A (IgA) cell wall polysaccharide antibodies, anti-laminarin (anti-L) and anti-chitin (anti-C), aid in the diagnosis and phenotype differentiation of Crohn's disease (CD) and ulcerative
Autor:
Avi Shtevi, Zamir Halpern, Aaron Lerner, Iris Dotan, Yaara Dgani, Mikael Schwartz, Sigal Fishman, Rom T. Altstock, Amir Karban, Larissa Spector, Oori Weishauss, Nir Dotan
Publikováno v:
Gastroenterology. 131:366-378
New serologic markers of inflammatory bowel disease may be useful for differentiating between Crohn's disease and ulcerative colitis and for disease stratification. We profiled sugar-binding antibodies to identify novel antiglycan antibodies that may
Autor:
Mikael Schwarz, Ariel Miller, Monica Gortler, Arnon Karni, Lea Glass-Marmor, Larissa Spector, Nir Dotan, Oori Weisshaus
Publikováno v:
Journal of the Neurological Sciences. 244:59-68
There is an unmet need to develop specific biomarkers for multiple sclerosis (MS) to aid in the diagnosis, improve the management of patients and the monitoring of the effectiveness of treatment. We have screened serum from patients with relapsing-re